We have a suspicion that you are an automated web bot software, not a real user. To keep our site fast for other users, we have slowed down this page. The slowdown will gradually disappear. If you think this is a mistake, please contact us at genome-www@soe.ucsc.edu. Also note that all data for hgGeneGraph can be obtained through our public MySQL server and all our software source code is available and can be installed locally onto your own computer. If you are unsure how to use these resources, do not hesitate to contact us.
UCSC Genome Browser Gene Interaction Graph
Gene interactions and pathways from curated databases and text-mining

◀ Back to IL6

IL6 — MIF

Text-mined interactions from Literome

Hines et al., Vet Microbiol 1999 : MIF-A3 does induce secretion of IL-6 , but does not induce secretion of TNFalpha, IL-1beta, and GM-CSF ... Since IL-6 appears to enhance growth of M. avium and MIF-A3 induces IL-6 secretion, MIF-A3 may be responsible for enhanced intracellular growth in M. avium infections and be a factor in the pathogenesis of M. avium infections
Santos et al., J Rheumatol 2004 (Arthritis, Rheumatoid) : Antagonism of p38 MAP kinase inhibited MIF induction of COX-2, PGE ( 2 ), and IL-6 ... MIF activates RA FLS COX-2 and IL-6 expression via p38 MAP kinase activation and induces IL-8 via p38 and ERK MAP kinase independent pathways
Chagnon et al., Circ Res 2005 (Heart Diseases...) : RNase protection assay (RPA) and Western blot established that MIF neutralization prevented LPS induced mRNA expression and production of heart derived inflammatory paracrine and autocrine cytokines such as IL-1s and IL-6
Herder et al., Diabetes Care 2006 (Diabetes Mellitus, Type 2...) : The associations of MIF with IGT and type 2 diabetes were independent of classical risk factors and of CRP and IL-6 and were much stronger before and after multivariate adjustment than the associations of CRP and IL-6 with IGT and type 2 diabetes
Stojanović et al., Immunology 2009 (Inflammation) : Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells
Balachandran et al., Bioorg Med Chem Lett 2009 : Of note, compounds 7, 22, 23, 24, 25 and 27 inhibited the spontaneous secretion/release/recognition of MIF from freshly isolated human peripheral blood mononuclear cells and, more importantly, inhibited the MIF induced production of interleukin-6 (IL-6) and/or interleukin-1beta (IL-1beta) significantly better than ISO-1
Kim et al., Korean J Intern Med 2010 (Arthritis, Rheumatoid) : MIF was also induced by interferon-?, CD40 ligand, interleukin-15 , interleukin-1ß, tumor necrosis factor-a, and transforming growth factor-ß
Chuang et al., BMC immunology 2010 (Vibrio Infections) : Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infection ... We conclude that MIF regulates V. vulnificus induced IL-6 production via NF-?B activation and that p38 MAPK activation in V. vulnificus infection is not MIF dependent
Stathas et al., Eur Rev Med Pharmacol Sci 2013 (Nasal Polyps) : MIF attenuates the suppressive effect of dexamethasone on IL-6 production by nasal polyp ... Inhibition of MIF by ( S,R)-3- ( 4-hydroxyphenyl ) -4,5-dihydro-5-isoxazole acetic acid methyl ester ( ISO-1 ), an inhibitor of MIF tautomerase activity, significantly enhanced the dexamethasone suppressive effect on IL-6 production ... MIF , presence in polyp tissue, attenuates the suppressive effect of dexamethasone on the production of IL-6 by this tissue, since the simultaneous use of its inhibitor ISO-1 leads to an enhancement of dexamethasone activity